A new treatment for bone loss caused by gum disease
A Novel Remedy for Periodontal Bone Loss
This study is testing a new oral gel to help treat gum disease and bone loss in adults, making it easier and less painful than current treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Periomics Care, LLC NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10705278 on NIH RePORTER |
What this research studies
This research focuses on developing a novel oral gel formulation aimed at treating periodontal bone loss, a common issue affecting many adults. The approach seeks to address the limitations of current treatments, which often involve painful and inconvenient mechanical procedures and antibiotics that may not effectively penetrate the biofilm associated with gum disease. By targeting the host response and providing a more user-friendly treatment option, this research aims to improve outcomes for patients suffering from periodontitis.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 30 years and older who are experiencing periodontal bone loss.
Not a fit: Patients with periodontal disease who are under 30 years old or those with other underlying health conditions that complicate treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more effective and less invasive treatment option for patients with periodontal bone loss.
How similar studies have performed: While there have been advancements in periodontal treatments, this specific approach using a novel oral gel formulation is relatively new and untested.
Where this research is happening
New York, United States
- Periomics Care, LLC — New York, United States (Active)
Researchers
- Principal investigator: Saxena, Deepak — Periomics Care, LLC
- Study coordinator: Saxena, Deepak
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.